Pharmaceuticals
Reckitt Benckiser confirms bidding for Merck & Co's consumer health business
29 Apr 2014
British consumer goods company Reckitt Benckiser has emerged as a front runner in the auction, although Bayer AG, Novartis, and Procter & Gamble Co are also in the race
Pfizer confirms AstraZeneca's rejection; to explore options
28 Apr 2014
US drugs giant Pfizer today confirmed that it had made a $98.67 billion (£58.73 billion) takeover offer for AstraZeneca, which was rejected by the UK-based company
Forest Labs to buy GI specialist Furiex in $1.46-bn deal
28 Apr 2014
Forest, which itself is in the process of being acquired by Actavis Plc for $25 billion, said that Actavis supported the deal
Greater investment needed to check malaria: WHO
25 Apr 2014
Britain’s Shire Plc recently rejected Allergan’s takeover approach: report
25 Apr 2014
Shire, the UK's third-biggest drug maker with a market cap of $33 billion, is itself an aggressive acquirer, having made 15 acquisitions since 2000
